EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Cardiovascular Manifestations and Management Recommendations for Ogden Syndrome

Rikhil Makwana, Rahi Patel, Rosemary O'Neill, Elaine Marchi, Gholson J Lyon

Pediatric Cardiology · 2026

DOI: 10.1007/s00246-025-03877-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Rikhil Makwana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA. Hauptthemen laut MEDLINE: Intellectual Disability, N-Terminal Acetyltransferase A, N-Terminal Acetyltransferase E, Developmental Disabilities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH NIGMS, New York State Office for People with Developmental Disabilities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NatA complex is composed of the NAA10, NAA15, and HYPK sub-units. It is primarily responsible for N-terminal acetylation, a critical post-translational modification in eukaryotes. Pathogenic variants within NAA10 cause Ogden Syndrome (OS), which is characterized by varying degrees of intellectual disability, hypotonia, developmental delay, and cardiac abnormalities. Although the cardiac manifestations of the disease have been described extensively in case reports, there has not been a study focusing on the cardiac manifestations and their recommended clinical cardiac management. In this study, we describe the cardiac manifestations of OS in a cohort of 85 probands. We found increased incidence of structural and electrophysiologic abnormalities, with particularly high prevalence of QT interval prolongation. Sub-analysis showed that male probands and those with variants within the NAA15-binding domain had more severe phenotypes than females or those with variants outside of the NAA15-binding domain. Our results suggest that an OS diagnosis should be accompanied by full cardiac workup with emphasis on echocardiogram for structural defects and EKG/Holter monitoring for electrophysiologic abnormalities. Additionally, we strongly recommend that the use of QT-prolonging drugs be followed up with routine electrophysiological monitoring or consultation with a pediatric cardiologist. We hope this study guides clinicians and caregivers treating patients with OS and moves the field toward a standardized diagnostic workup for patients with this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EDevelopmental DisabilitiesHumansFemaleMaleChildChild, PreschoolElectrocardiographyAdolescentInfantEchocardiographyPhenotype

Stichwörter der Autor:innen

ArrhythmiasCardiac anomaliesNAA1-related neurodevelopmental syndromeNAA15Ogden syndrome

Substanzen

N-Terminal Acetyltransferase AN-Terminal Acetyltransferase E

Autor:innen und Institutionen

  • Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.
  • Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA. gholsonjlyon@gmail.com.
  • George A. Jervis Clinic, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA. gholsonjlyon@gmail.com.
  • Biology PhD Program, The Graduate Center, The City University of New York, New York, NY, USA. gholsonjlyon@gmail.com.

Förderung

  • NIH NIGMS
  • New York State Office for People with Developmental Disabilities

Zitieren

APA

Makwana, R., Patel, R., O'Neill, R., Marchi, E., & Lyon, G. J. (2026). The Cardiovascular Manifestations and Management Recommendations for Ogden Syndrome. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-03877-7

Vancouver

Makwana R, Patel R, O'Neill R, Marchi E, Lyon GJ. The Cardiovascular Manifestations and Management Recommendations for Ogden Syndrome. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-03877-7

BibTeX
@article{Makwana2026,
  author = {Makwana, Rikhil and Patel, Rahi and O'Neill, Rosemary and Marchi, Elaine and Lyon, Gholson J},
  title = {The Cardiovascular Manifestations and Management Recommendations for Ogden Syndrome},
  journal = {Pediatric Cardiology},
  year = {2026},
  doi = {10.1007/s00246-025-03877-7}
}
Kostenlos starten →